Introduction c-fos gene is rapid and transiently expressed in response to diverse stimuli in a variety of cells (Curran and Morgan, 1987) . c-Fos dephosphorylated on tyrosine (c-Fos) is a short-lived transcription factor component that heterodimerizes with various protein partners of the activator protein-1 (AP-1) transcription complex. However, its regulatory activity is not restricted to its transcription factor capacity. c-Fos is also capable of associating to endoplasmic reticulum (ER) membranes and activating the synthesis of phospholipids (Guido et al., 1996; Bussolino et al., 1998 Bussolino et al., , 2001 ) even in cell extracts nuclei free (Gil et al., 2004) . The basic domain of c-Fos corresponding to amino acids 139-159 is relevant both for c-Fos/ER association and for the activation of phospholipid synthesis (Gil et al., 2004) .
As c-Fos modulates different key cellular events such as cell proliferation, growth and differentiation (Shaulian and Karin, 2001) , it seems reasonable to expect that several regulatory mechanisms will concertedly act to control tightly its expression and coordinate its different activities. Undoubtedly, post-translational modification of proteins is an exquisite control mechanism to restrict/ activate proteins (Alitalo et al., 1990; Okazaki and Sagata, 1995) . In this regard, c-Fos serine/threonine (ser/thr) phosphorylation has been extensively studied in the past two decades (Herdegen and Leah, 1998; Jacobs et al., 1999) linking this phenomenon to protein stability (Gius et al., 1990; Tsurumi et al., 1995) , signal transduction (Stork, 2002; Tanos et al., 2005) and transactivation capacity (Allegretto et al., 1990; Abate et al., 1993) . Herein, we describe the phosphorylation of c-Fos tyrosine (tyr) residues and demonstrate its regulatory implications in events related to c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation.
Results
As for other cells (Herdegen and Leah, 1998; Bussolino et al., 2001) , quiescent T98G cells (from now on called ÀFBS cells) express trace amounts of c-Fos (Figure 1 ) but, as the time after induction to re-enter growth by feeding with fetal bovine serum ( þ FBS) progresses, cells show two c-Fos expression waves both at the mRNA ( Figure 1a ) and the protein (Figure 1b and c) level. This newly synthesized c-Fos colocalizes with the ER marker calnexin in both waves of expression, whereas nuclear-localized c-Fos can be evidenced in the second one (Figure 1c ).
c-Fos tyr phosphorylation influences c-Fos/ER association/dissociation
To know if phosphorylation of c-Fos tyr residues influences the c-Fos/ER dissociation/association state in quiescent and growing cells, þ FBS or ÀFBS cell homogenates were immunoblotted (IB) for c-Fos. As expected, the ÀFBS cells showed much lower levels of c-Fos than those in cells cultured þ FBS for 60 min (Figure 2a, left panel) . However, examining the phosphorylation state of c-Fos tyr-residues by immunoprecipitating (IP) for phospho-tyrosine (P-Tyr) followed by IB for c-Fos, showed that c-Fos in the ÀFBS cells was tyr-phosphorylated, whereas phosphorylated c-Fos was at the limit of detection in cells cultured 60 min þ FBS (Figure 2a To examine if phosphorylated c-Fos was present in quiescent cells or was induced upon FBS treatment, cells were fed FBS in the presence or absence of the protein synthesis inhibitor cycloheximide. As can be observed in Figure 2b , both in the presence and absence of cycloheximide, cell content of tyr-phosphorylated c-Fos is similar and in both cases rapidly decreases upon induction of cells to re-enter growth. These results indicate the presence of phosphorylated c-Fos in quiescent cells that is rapidly dephosphorylated rather than a de novo synthesis of c-Fos.
The subcellular localization of tyr-phosphorylated c-Fos (P-c-Fos) and dephosphorylated c-Fos (c-Fos) was examined by centrifugation of ÀFBS and þ FBS cell homogenates for 2 h at 100 000 g to separate the (right panel) of cycloheximide (50 mg/ml) were cultured for the indicated times þ FBS. Cell homogenates were subjected to IP for c-Fos followed by IB for c-Fos or for P-Tyr (top) or were subjected to IP for P-Tyr followed by IB for c-Fos (bottom) as indicated. Note the rapid decay of P-c-Fos in cells cultured either in the absence or presence of cycloheximide. soluble fraction (SF) and the membrane fraction (MF) followed by IP of c-Fos from each fraction. In ÀFBS cells, the small amount of c-Fos expressed was recovered in SF contrasting with its recovery in MF in þ FBS cells (Figure 3a , left panel). However, when the tyr-phosphorylated state of immunoprecipitated c-Fos was examined, most P-c-Fos is recovered in SF, whereas c-Fos was in MF (Figure 3a , right panel). Addition of phenylarsine oxide (PAO), an inhibitor of tyr phosphatases (Medema et al., 1991) These results in agreement with our previous data (Bussolino et al., 2001; Gil et al., 2004) pointing that c-Fos/ER association is relevant for the c-Fos-dependent activation of phospholipid synthesis, highlight a role of the c-Fos tyr-phosphorylation state in regulating this association process required for phospholipid synthesis activation.
c-Fos/ER association is also relevant for cell cycle progression, as no proliferation is observed after culturing cells for 3 days ÀFBS or in þ FBS, if ASO or PAO are added to the culture medium, contrasting with the four-to fivefold increase in cell number observed in sister cultures þ FBS or þ FBS, þ SO (c-fos mRNA sense oligonucleotide) (Figure 5c ).
c-Fos but not P-c-Fos activates phospholipid synthesis in-vitro
We compared the capacity of endogenous P-c-Fos purified from ÀFBS cell homogenates with that of recombinant c-Fos to activate phospholipid labeling. Recombinant c-Fos promotes a two-to threefold increase in the in vitro labeling of phospholipids, whereas endogenous P-c-Fos purified from ÀFBS cells does not activate even when assayed at 10 Â the concentration of c-Fos required to attain maximal activation (1 ng/mg cell homogenate protein) (Figure 6a ) (Gil et al., 2004) . Dephosphorylation of P-c-Fos by pre-incubation with calf intestinal alkaline phosphatase (CIAP) (Kaludov et al., 1996) restores phospholipid synthesis activation capacity, whereas CIAP has no effect on the activation capacity of dephosphorylated c-Fos (Figure 6a ). Fractionation of reaction mixtures into SF and MF followed by IP for P-Tyr shows P-c-Fos recovered in SF (Figure 6b ). Phosphorylation state of c-Fos and P-c-Fos at the end of the assays of Figure 6a were unchanged as controlled by IP for P-Tyr or for c-Fos followed by IB for c-Fos (Figure 6c ).
Identification of phosphorylatable c-Fos tyr residues
Four of the seven tyr residues of c-Fos were predicted as phosphorylatable according to NetPhos 2.0 software (Blom et al., 1999) . To map which are phosphorylated, point replacements of tyr residues by phenylalanine ones were introduced into his-c-myc-tagged c-Fos, replacing (Y/F) at Y10, Y30, Y106 in the N-terminal region and Y337 in the C-terminal end. Quiescent cells were transfected to express the corresponding mutated protein and after 2 days in culture ÀFBS, cell homogenates were subjected to IP for c-myc followed by IB for P-Tyr. Figure 7a shows that Y/F substitutions in position 10 or 30 abolish phosphorylation of the protein, whereas those in position 106 and 337 have no effect. Interestingly, substitution of either Y10 or Y30 impairs the phosphorylation of the other suggesting that their phosphorylation is cooperative (Figure 7a) .
The subcellular localization of each point mutated c-Fos was examined by separating cell homogenates from transfected cells cultured for 2 days ÀFBS into SF and MF followed by IB for c-myc. Figure 7b shows that Y10/F10 and Y30/F30 were mostly recovered in MF as expected according to their non-phosphorylatable state, whereas phosphorylated Y106/F106 and Y337/F337 were recovered in SF. These results support that only 
Tyr-c-Fos phosphorylation regulates phospholipid synthesis
MM Portal et al Y10, Y30-dephosphorylated-c-Fos, is capable of associating to the ER and activating phospholipid synthesis. To further confirm these results, quiescent transfected cells were double immunostained for c-myc and calnexin and subjected to confocal microscopy examination. 
Discussion
Activation of genes is a common feature of the cellular response to growth-promoting agents, particularly that of early response genes that encode transcription factors. Consequently, it is not surprising to find c-Fos, a member of the AP-1 family of transcription factors, induced in response to trophic factors. However, c-Fos is not only a transcription factor, it is also an activator of the synthesis of phospholipids and as such, not only determines the rate and extent of neurite growth in differentiating PC12 cells, its presence or absence will determine that these cell will or will not grow (Gil et al., 2004) . In the case of T98G cells shown herein, proliferation is also strictly dependent on c-Fos expression and phospholipid synthesis activation: cell proliferation is not observed in the absence of dephosphorylated c-Fos in which phospholipid synthesis activation does not occur either. The increase in the transcription factor capacity of c-Fos by the phosphorylation of multiple ser/thr residues within its carboxy-terminal transactivation domain has been precisely demonstrated (Karin, 1994; Monje et al., 2003) . However, to our best knowledge, no phosphorylation over c-Fos tyr residues had been previously observed although some groups have specifically examined this possibility (Coronella-Wood et al., 2004) . This is probably so because upon activation of cells, phosphorylation over ser/thr residues and over tyr ones run in opposite directions: whereas a number of extracellular signal-regulated protein kinases phosphorylate c-Fos ser/thr residues increasing its transcriptional activity, tyr phosphatases dephosphorylate c-Fos tyr residues enabling c-Fos/ER association and consequently, phospholipid synthesis activation.
c-Fos tyr dephosphorylation appears as a reasonable mechanism for cells to respond rapidly to their demands of lipids, relying less on newly synthesized c-Fos, a timedemanding procedure. Interestingly, at times as short as 1 min after inducing quiescent NIH 3T3 fibroblasts to re-enter growth, phospholipid synthesis activation can be evidenced and the lipids predominantly labeled are the second-messenger family of polyphosphoinositides. By contrast, at later times after growth-induction, lipids components of cell membranes are predominantly labeled (Bussolino et al., 2001) . Examination of quiescent NIH 3T3 fibroblasts also evidenced the presence of P-c-Fos (Figure 1 of Supplementary Information) as occurs in T98G cells. This points to a common regulatory pathway for c-Fos/ER association/ dissociation in diverse cell types.
In summary, our results evidence a new regulatory mechanism for a quite recently described cellular activity of c-Fos, its capacity to associate to the ER and activate phospholipid synthesis. Even if further work is required to establish the precise molecular mechanism involved in this association and activation process, previous results have shown that only specific enzymes of the pathway of phospholipid synthesis are modulated by c-Fos (de Arriba Zerpa et al., 1999) . In consequence, two possibilities appear at first sight as simple and feasible to attain this activation: one is a direct interaction between c-Fos and the enzymes it activates and the other is a modification of the enzyme's ER membrane environment upon c-Fos association. The former should not be disregarded as preliminary unpublished results from our laboratory are evidencing a direct interaction between c-Fos and enzymes it modulates. The latter has strong biophysical evidences showing that c-Fos can differentially interact with lipids in monolayer paradigms, sensing its composition (Borioli et al., , 2005 . Even more likely seems to be the possibility that both mechanisms act concertedly to assure a cell its provision of phospholipids according to its demands, initially by regulating the association of c-Fos to the ER (dephosphorylating Y10 and/or Y30 of c-Fos) followed by an increase in the cellular content of this protein.
Materials and methods
Cell cultures, transfections and extract preparation T98G cells (ATCC, Manassas, VA, USA) were grown under standard culture conditions in Dulbecco's modified Eagle medium (Gibco, BRL, Invitrogen, Carlsbad, CA, USA) supplemented with 10% FBS. After desired confluence growth was continued for 36 h ÀFBS to achieve quiescence. Cells were induced to re-enter growth by addition of 10% FBS ( þ FBS) or cultures continued ÀFBS for the indicated times. For experiments with antisense morpholino oligonucleotide (ASO): 5 0 CCA TGA TGT TCT CGG GTT TCA ACG C 3 0 , or its corresponding control (SO): 5 0 CGC AAC TTT GGG CTC TTG TAG TAC CC 3 0 (Gene Tools, Philomath, OR, USA), cells were fed the oligonucleotide 3 h before the initiation of FBS treatment and cell cultures continued for the times indicated in each case. For cycloheximide experiments, cells were fed the protein synthesis inhibitor at 50 mg/ml of culture medium, 5 min before FBS treatment. Inhibition of protein synthesis with cycloheximide was >90% at 60 min of inhibitor treatment as controlled by feeding cells with 35 S-methionine (10 mCi/ml culture medium) (Amersham, UK) together with FBS addition.
Cell transfections with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) were according to manufacturer's protocol. Transfected cells were grown ÀFBS for 36 h more and then treated as indicated in each case. Treatment of cells with PAO was achieved by addition to culture media of dimethyl sulfoxide-diluted PAO (50 mM) for a final concentration of 50 mM, 1 h before FBS treatment.
Cells were rinsed with ice-cold 10 mM phosphate-buffered saline (PBS) and harvested in modified radioimmunoprecipitation assay (RIPA) buffer (Acquaviva et al., 2001) .
For subcellular fractionation assays, cells were rinsed as described, harvested in water and ultracentrifuged for 2 h at 100 000 g. Each fraction was resuspended in modified RIPA buffer supplemented with protease inhibitor cocktail (10% v/v) (Sigma, St Louis, MO, USA).
Northern blot
Total RNA purified by the TRIZOL method (Invitrogen, USA), c-Fos mRNA and a-Tub mRNA were detected by standard techniques (Molecular Cloning, Cold Spring Harbor Laboratory Press).
Electrophoresis, IB and immunofluorescence assays Total homogenate (10 mg) or immunoprecipitated proteins were fractionated through sodium dodecyl sulfate-containing 12% polyacrylamide gels and electrotransferred at 300 mA during 65 min. Immunodetection of c-Fos or point mutated c-Fos was carried at room temperature by blocking of membranes for 1 h with 10 mM PBS, 0.1% Tween 20 containing 5% non-fat dried milk, followed by incubation with c-Fos D1 monoclonal antibody (mAb) (Santa Cruz Biotechnology, Santa Cruz, CA, USA, dilution 1/5000) or a-tubulin DM1A mAb (Sigma, USA, dilution 1/5000) overnight at 41C in PBS-Tween 20. Membranes were washed twice (15 min) with PBS-Tween 20 and incubated 2 h at room temperature with biotin-conjugated anti-mouse antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA dilution 1/15000), washed twice with PBS-Tween 20 and incubated 2 h with streptavidinperoxidase-conjugated antibody (Amersham Biosciences, UK, dilution 1/60 000). Immunodetection was by ECL plus (Amersham Biosciences, UK). For P-Tyr detection, samples incubated overnight with PY20 mAb (Sigma, USA) diluted 1/750 were processed as described above using the same antibody. For IP assays, 300 mg of homogenate protein was immunoprecipitated with the desired antibody overnight, washed and recovered in Laemmli loading buffer. Immunofluorescence detection and analysis was as by Gil et al. (2004) . Antibody specificity control is shown in Figure 2 of Supplementary Information.
Phospholipid labeling
In vitro phospholipid labeling capacity of T98G cells was as described previously (Gil et al., 2004) . Reactions were initiated by addition of 100 mg of cellular homogenate or of the protein obtained in the corresponding fraction starting with 100 mg of cell homogenate and stopped with trichloroacetic acidphosphotungstic acid (PTA) (final concentration of 5-0.5% w/v). Phospholipid labeling was determined as described (Guido and Caputto, 1990 ).
Purification of recombinant and endogenous tyr phosphorylated c-Fos
His-tagged recombinant c-Fos was purified as described previously . P-c-Fos was purified from T98G cell homogenates by two rounds of immunoaffinity. The first was designed to obtain c-Fos via the passage through a BrCN-activated Sepharose 4B column crosslinked to c-Fos 4 polyclonal antibody (Santa Cruz Biosciences, UK) according to the manufacturer's prospect (Sigma, USA). c-Fos was eluted in acetate buffer pH 4 (0.1 M sodium acetate, 0.5 M NaCl) and adjusted to pH 8 with 1 M Tris-HCl. The second round was performed using a monoclonal anti-phosphotyrosine antibody-agarose-conjugated resin (Sigma, USA) and eluted as described above. After purification, protein concentration of each preparation was by the method of Bradford (1976) .
For dephosphorylation assays, alkaline phosphatase CIAP (Invitrogen, USA) was used according to the manufacturer's instructions and volume adjusted by centricom filters.
In Silico c-Fos putative phosphorylation sites and site directed mutagenesis Putative phosphorylation sites were determined by Netphos 2.0 software (PROSITE -EMBL) according to Blom et al. (1999) and were mutated over pDS56HisFos by the megaprimer-mediated PCR method. PCR products were cloned into pCDNA3.1 A His-Myc at KpnI and XbaI site.
Abbreviations c-Fos, c-Fos dephosphorylated on tyrosine; CIAP, calf intestine alkaline phosphatase; IB, immunoblot assays; IP, immunoprecipitation assays; PAO, phenylarsine oxide; P-c-Fos, tyrosine-phosphorylated c-Fos.
